Literature DB >> 21778345

Could CR mean cure?

Bart Barlogie1, John Crowley.   

Abstract

Year:  2011        PMID： 21778345     DOI： 10.1182/blood-2011-05-350322

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Update on risk stratification and treatment of newly diagnosed multiple myeloma.

Authors:  Prashant Kapoor; S Vincent Rajkumar
Journal:  Int J Hematol       Date:  2011-10-18       Impact factor: 2.490

2.  NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.

Authors:  Sathisha Upparahalli Venkateshaiah; Sharmin Khan; Wen Ling; Rakesh Bam; Xin Li; Frits van Rhee; Saad Usmani; Bart Barlogie; Joshua Epstein; Shmuel Yaccoby
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

3.  Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.

Authors:  Sarah Waheed; Alan Mitchell; Saad Usmani; Joshua Epstein; Shmuel Yaccoby; Bijay Nair; Rudy van Hemert; Edgardo Angtuaco; Tracy Brown; Twyla Bartel; James McDonald; Elias Anaissie; Frits van Rhee; John Crowley; Bart Barlogie
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

4.  The current status of minimal residual disease assessment in myeloma.

Authors:  S K Kumar; S V Rajkumar
Journal:  Leukemia       Date:  2014-02       Impact factor: 11.528

5.  Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?

Authors:  S Z Usmani; J Crowley; A Hoering; A Mitchell; S Waheed; B Nair; Y AlSayed; F Vanrhee; B Barlogie
Journal:  Leukemia       Date:  2012-06-18       Impact factor: 11.528

6.  Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myeloma.

Authors:  Martin Bøgsted; Anders E Bilgrau; Christopher P Wardell; Uta Bertsch; Alexander Schmitz; Julie S Bødker; Malene K Kjeldsen; Hartmut Goldschmidt; Gareth J Morgan; Karen Dybkaer; Hans E Johnsen
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.